跳至主要内容
临床试验/NCT06094036
NCT06094036招募中不适用

Physical Exercise as a Sustainability Tool in Men Affected With Metabolic Syndrome-related Late-onset Central Hypogonadism: Role of Endocrine-metabolic and Neurovegetative Outcomes

Istituto Auxologico Italiano1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2023年1月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
72
试验地点
1
主要终点
change in hypothalamic-pituitary-gonadal axis function

研究概览

简要总结

Aim of this project is to delineate sustainable physical exercise programs and to assess the effects of such programs mainly on endocrine-metabolic and neurovegetative outcomes in a cohort of men with metabolic syndrome-related late-onset central hypogonadism.

Participants will undergo a personalised exercise program. After 6 months they will be subdivided into two groups, according to the weekly physical activity volume actually performed (above or below 600 MET·minutes/week). Changes in endocrine-metabolic and neurovegetative outcomes will be compared between the two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • diagnosis of late-onset central hypogonadism: total T levels < 8 nmol/L (or < 12 nmol/L in the presence of calculated free T < 225 pmol/L) combined with sexual symptoms (erectile dysfunction, low libido and loss of waking erections) [12];
  • diagnosis of metabolic syndrome, defined as association of waist circumference (WC) > 94 cm and at least two among the following criteria: triglycerides ≥ 150 mg/dl, HDL-C < 40 mg/dl, glucose > 100 mg/dl, blood pressure (BP) ≥ 130/85 mmHg [33];
  • ability to give informed consent, in accordance with good clinical practice rules and applicable national laws.

排除标准

  • History of hypothalamus-pituitary organic disorders and/or testicular diseases;
  • impossibility to assess cardiac autonomic regulation due to arrhythmias and/or current treatment for heart rate (HR) control (e.g., beta-blockers, antiarrhythmics);
  • impossibility to undergo clinical assessment;
  • impossibility or contraindications to perform exercise program (for instance, psychiatric disorders, severe musculoskeletal diseases, arrhythmias);
  • inability to give informed consent or unwillingness to be enrolled in the study.

研究组 & 干预措施

weekly physical activity volume performed above 600 MET·minutes/week

Other

Exercise program requiring clear definition of modality, intensity, frequency, duration and progression of exercise, tailored on patient's clinical conditions and goals.

干预措施: Structured and personalized program of physical exercise (Behavioral)

weekly physical activity volume performed below 600 MET·minutes/week

Other

Exercise program requiring clear definition of modality, intensity, frequency, duration and progression of exercise, tailored on patient's clinical conditions and goals.

干预措施: Structured and personalized program of physical exercise (Behavioral)

结局指标

主要结局

change in hypothalamic-pituitary-gonadal axis function

时间窗: 6 months

particularly testosterone levels (nmol/l)

次要结局

  • Change in erythrocyte sedimentation rate(6 months)
  • Change in C-reactive protein(6 months)
  • Change in glucose profile(6 months)
  • Change in nutrition quality(6 months)
  • Change in kidney function(6 months)
  • Change in total cholesterol(6 months)
  • Change in HDL cholesterol(6 months)
  • Change in alanine aminotransferase(6 months)
  • Change in perception of stress, fatigue, and somatic symptoms(6 months)
  • Change in body composition(6 months)
  • Change in serum skeletal isoenzyme of alkaline phosphatase(6 months)
  • Change in C-terminal telopeptide of type I collagen(6 months)
  • Change in triglycerides(6 months)
  • Change in aspartate aminotransferase(6 months)
  • Change in cardiac autonomic regulation(6 months)
  • Change in weekly physical activity volume(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验